Trial Profile
Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy in Patients With Ragweed Pollinosis: a Phase III Randomized and Controlled Clinical Study. [Confronto dell`efficacia e della sicurezza di diversi schemi di somministrazione dell`immunoterapia sub-linguale in pazienti con pollinosi da ambrosia: studio clinico randomizzato controllato di fase III].
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary) ; Birch pollen allergy immunotherapy
- Indications Ragweed pollen hypersensitivity
- Focus Therapeutic Use
- 16 Oct 2012 New source identified and integrated (EudraCT2011-001682-41: European Clinical Trials Database).
- 05 Jan 2012 New trial record